Christian Riegert

Title: Christian Riegert: Innovator in Pharmaceutical Chemistry

Introduction

Christian Riegert is a notable inventor based in Sierentz, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds. His work has led to advancements in the preparation of specific polymorphs that are crucial for drug formulation.

Latest Patents

Riegert holds a patent for the "Preparation of anhydrous and hydrated polymorphs 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-YL)-1H-benzimidazol-2-YL]-1H-quinolin-2-one-lactic acid salt." This technology provides methods for creating anhydrous crystalline Form II and monohydrate crystalline Form B of the lactic acid salt of the compound mentioned. His innovative approach enhances the efficiency and effectiveness of pharmaceutical formulations.

Career Highlights

Christian Riegert is associated with Novartis AG, a leading global healthcare company. His role at Novartis has allowed him to work on cutting-edge research and development projects that aim to improve patient outcomes through advanced medication solutions.

Collaborations

Riegert has collaborated with esteemed colleagues such as Arnaud Grandeury and Andreas Schreiner. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pharmaceutical sector.

Conclusion

Christian Riegert's contributions to pharmaceutical chemistry exemplify the impact of innovative thinking in drug development. His patent and work at Novartis AG highlight his commitment to advancing healthcare solutions.